QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.60 (-1.19%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.68 (-0.06%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

ZyVersa Therapeutics (ZVSA) Short Interest Ratio & Short Volume

Notice: Trading of ZyVersa Therapeutics halted at 09:32 AM EST due to "LULD pause".
$1.08
+0.28 (+34.83%)
(As of 04:33 PM ET)

ZyVersa Therapeutics Short Interest Data

Current Short Volume
193,500 shares
Previous Short Volume
30,000 shares
Change Vs. Previous Month
+545.00%
Dollar Volume Sold Short
$110,314.35
Short Interest Ratio / Days to Cover
0.2
Last Record Date
January 31, 2024
Outstanding Shares
1,240,000 shares
Float Size
12,550,000 shares
Short Percent of Float
1.54%
Today's Trading Volume
88,050,086 shares
Average Trading Volume
3,325,958 shares
Today's Volume Vs. Average
2,647%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling ZyVersa Therapeutics ?

Sign up to receive the latest short interest report for ZyVersa Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

ZVSA Short Interest Over Time

ZVSA Days to Cover Over Time

ZVSA Percentage of Float Shorted Over Time


ZyVersa Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/2024193,500 shares $110,314.35 +545.0%1.5%0.2 $0.57
1/15/202430,000 shares $22,608.00 -51.6%0.2%0 $0.75
12/31/202362,000 shares $55,800.00 +38.1%0.5%0.1 $0.90
12/15/202344,900 shares $34,797.50 +152.3%0.4%0.1 $0.78
11/30/202317,800 shares $40,495.00 -99.2%0.1%0 $2.28
11/15/20232,300,000 shares $191,130.00 +25.7%18.3%0.3 $0.08
10/31/20231,830,000 shares $150,060.00 -26.8%14.6%0.3 $0.08
10/15/20232,500,000 shares $324,750.00 +86.6%19.9%0.5 $0.13
9/30/20231,340,000 shares $173,530.00 -63.1%10.7%0.3 $0.13
9/15/20233,630,000 shares $540,870.00 +1,168.8%28.9%0.8 $0.15
8/31/2023286,100 shares $40,683.42 -9.2%2.3%0.1 $0.14
8/15/2023315,100 shares $50,416.00 -52.4%2.5%0.2 $0.16
7/31/2023662,600 shares $114,298.50 -43.9%5.3%0.3 $0.17
7/15/20231,180,000 shares $293,466.00 +148.0%N/A0.4 $0.25
6/30/2023475,900 shares $116,833.45 -37.4%N/A0.2 $0.25
6/15/2023760,400 shares $250,932.00 +6.7%N/A0.4 $0.33
5/31/2023712,400 shares $260,738.40 +178.9%N/A0.4 $0.37
5/15/2023255,400 shares $110,409.42 No ChangeN/A0.2 $0.43













ZVSA Short Interest - Frequently Asked Questions

What is ZyVersa Therapeutics' current short interest?

Short interest is the volume of ZyVersa Therapeutics shares that have been sold short but have not yet been closed out or covered. As of January 31st, traders have sold 193,500 shares of ZVSA short. 1.54% of ZyVersa Therapeutics' shares are currently sold short. Learn More on ZyVersa Therapeutics' current short interest.

What is a good short interest percentage for ZyVersa Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.54% of ZyVersa Therapeutics' floating shares are currently sold short.

Is ZyVersa Therapeutics' short interest increasing or decreasing?

ZyVersa Therapeutics saw a increase in short interest in January. As of January 31st, there was short interest totaling 193,500 shares, an increase of 545.0% from the previous total of 30,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is ZyVersa Therapeutics' float size?

ZyVersa Therapeutics currently has issued a total of 1,240,000 shares. Some of ZyVersa Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ZyVersa Therapeutics currently has a public float of 12,550,000 shares.

How does ZyVersa Therapeutics' short interest compare to its competitors?

1.54% of ZyVersa Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ZyVersa Therapeutics: Galmed Pharmaceuticals Ltd. (0.32%), GRI Bio, Inc. (5.96%), Bellerophon Therapeutics, Inc. (0.55%), Revelation Biosciences, Inc. (30.78%), Athersys, Inc. (12.51%), Aditxt, Inc. (2.08%), China SXT Pharmaceuticals, Inc. (14.79%), SciSparc Ltd. (1.13%), Cingulate Inc. (0.96%), Avalo Therapeutics, Inc. (90.33%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short ZyVersa Therapeutics stock?

Short selling ZVSA is an investing strategy that aims to generate trading profit from ZyVersa Therapeutics as its price is falling. ZVSA shares are trading up $0.52 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against ZyVersa Therapeutics?

A short squeeze for ZyVersa Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ZVSA, which in turn drives the price of the stock up even further.

How often is ZyVersa Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZVSA, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:ZVSA) was last updated on 2/26/2024 by MarketBeat.com Staff